Pharmaceuticals News and Research

RSS
Gel significantly increases sexual activity in surgically menopausal women

Gel significantly increases sexual activity in surgically menopausal women

New therapy under development for the treatment of irritable bowel syndrome

New therapy under development for the treatment of irritable bowel syndrome

Uterine fibroid treatment option 'safe and effective'

Uterine fibroid treatment option 'safe and effective'

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

New insights into hormone therapy show when estrogen best aids brain

New insights into hormone therapy show when estrogen best aids brain

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Human Genome Sciences announces agreement with GSK for development of drug to treat diabetes

Call for a Senate Inquiry into the pharmacy industry in Australia

Call for a Senate Inquiry into the pharmacy industry in Australia

New Drug Application for Velac accepted for filing by the FDA

New Drug Application for Velac accepted for filing by the FDA

Agreement reached on new community pharmacy contract

Agreement reached on new community pharmacy contract

Infectious diseases physicians call for financial incentives for industry

Infectious diseases physicians call for financial incentives for industry

Boehringer Ingelheim  - New Drug Application (NDA) for tipranavir

Boehringer Ingelheim - New Drug Application (NDA) for tipranavir

Drastic market changes with MRI contrast media and PET radiopharmaceuticals emerging as most promising segments

Drastic market changes with MRI contrast media and PET radiopharmaceuticals emerging as most promising segments

Cost cutting measures and patent expirations to propel the European generics and biogenerics market

Cost cutting measures and patent expirations to propel the European generics and biogenerics market

Study will evaluate arsenic exposure from the environment and its potential carcinogenic effects

Study will evaluate arsenic exposure from the environment and its potential carcinogenic effects

Chiron responds to FDA announcement

Chiron responds to FDA announcement

Researchers have developed a novel drug-antidote pair

Researchers have developed a novel drug-antidote pair

Asthma research company Synairgen to float on London's Alternative Investment Market

Asthma research company Synairgen to float on London's Alternative Investment Market

Teva Pharmaceutical granted FDA approval for Flumazenil injection

Teva Pharmaceutical granted FDA approval for Flumazenil injection

Ecstasy study identifies potentially lethal combination

Ecstasy study identifies potentially lethal combination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.